Prevalence of Hyperuricemia and Gout in Renal Transplanted Recipients
The Internet Journal of Nephrology · 2005
DOI: 10.5580/218e ↗At a glance
Journal article in The Internet Journal of Nephrology, 2005.
Abstract (original language)
Aim
Although the prevalence of hyperuricemia is high after renal transplantation, investigation has shown that gout occurs rarely in these patients. The present study was designed to investigate the prevalence of hyperuricemia and gout in renal transplant patients. Materials and methods: The records of 155 patients (M/F, 119/36, mean age 34.7±9.7 years) who underwent renal transplantation in between 2000 and 2002 were retrospectively re-evaluated. Patients with at least 2 years stable graft survival duration were included. For each individual, mean value of serum uric acid levels that were repeated in each routine visits approximately every 6 months in transplantation outpatient clinic were used. Patient demographics, immunosuppressive drug regimens and other medications were also recorded. Hyperuricemia was defined as serum uric acid level of >6 mg/dl in females and 7 mg/dl in males. Clinical gout was defined as hyperuricemia with gouty arthritis and tophi.
Results
Hyperuricemia and gout were seen in 95 patients, and 13 patients, respectively. Mean serum uric acid levels were found to be independent from patients' age, sex, donor type, and immunosuppressive drug regimen.
Conclusion
Our study confirmed that although hyperuricemia is a common complication in renal transplant recipients, gout is not seen often in these populations.
Cite
APA
(2005). Prevalence of Hyperuricemia and Gout in Renal Transplanted Recipients. The Internet Journal of Nephrology. https://doi.org/10.5580/218e
Vancouver
Prevalence of Hyperuricemia and Gout in Renal Transplanted Recipients. The Internet Journal of Nephrology. 2005. doi:10.5580/218e
BibTeX
@article{euvimed2005,
title = {Prevalence of Hyperuricemia and Gout in Renal Transplanted Recipients},
journal = {The Internet Journal of Nephrology},
year = {2005},
doi = {10.5580/218e}
}
EUVIMED